Which test would you like to explore?
Gemelli Biotech’s Scientific Advisory Board brings together leading clinical and research experts from the United States, Canada, and Mexico to guide the company’s scientific direction and validate its approach. This expert group supports Gemelli’s mission to advance non-invasive precision diagnostics by ensuring the highest level of scientific rigor and clinical relevancy across its programs.
Dr. Brenner is a Professor of Medicine and Surgery in the Division of Gastroenterology at Northwestern University and serves as Director of the Neurogastromotility and Interdisciplinary Bowel Dysfunction programs, and Motts Tonelli GI Physiology Laboratory. He is also an active Irene D. Pritzker Foundation Research Scholar. Dr. Brenner focuses his clinical and research pursuits on a wide range of motility topics including IBS, constipation, opioid related constipation, fecal incontinence, gastroparesis and scleroderma. He has published more than 150 articles, abstracts, and online materials on these subjects, and has lectured both nationally and internationally in these areas. He acts as a reviewer and editor for multiple GI peer-reviewed journals and is a former associate editor of the American Journal of Gastroenterology. He serves as a member of the board of directors for the International Foundation for Gastrointestinal Disorders, on the Rome Foundation committee on clinical trial design, and serves or has served on multiple AGA and ACG committees including research, education, and digital publications and communications. Dr. Brenner is a fellow of the American College of Gastroenterology, American Gastroenterological Association, and Rome Foundation. He has been appointed to the peer perspective board of Healio Gastroenterology and has been named to the Healio 200 top innovators in gastroenterology and hepatology and Best Doctors in America lists. In his free time, Dr. Brenner is an avid practitioner of Shotokan karate, holds a 3rd degree black belt in this art, and served as head coach of the US Junior National Karate Team at the World Maccabiah Games in Israel in 2022 where his daughter was the only American karate athlete to win a gold medal.
Northwestern University
Dr. Chey received a medical degree & training in internal medicine at Emory University School of Medicine. He completed a fellowship in gastroenterology and has remained as faculty at the University of Michigan in Ann Arbor where he is currently the Timothy T. Nostrant Collegiate Professor of Gastroenterology & Nutrition Sciences.
His research interests focus on the diagnosis & treatment of functional bowel disorders and H. pylori infection. He is a medical innovator and holds 3 patents. He co-founded “My Total Health” (https://mygihealth.io/), a company developing novel health information technology solutions for persons with GI problems. Dr Chey is former co-Editor-in-Chief of the American Journal of Gastroenterology and has authored more than 300 manuscripts, reviews, chapters & books. Dr. Chey is a member of the Board of Trustees of the American College of Gastroenterology, Board of Directors of the Rome Foundation, and Council of the American Neurogastroenterology & Motility Society.
He has been elected to “Best Doctors” since 2001 and received the Dean’s Outstanding Clinician Award and Dean’s Award for Innovation and Commercialization at the University of Michigan and the Distinguished Clinician Award from the American Gastroenterological Association.
University of Michigan
Brian E. Lacy, Ph.D., M.D., FACG is currently Senior Associate Consultant at Mayo Clinic Jacksonville. He previously worked at the Dartmouth-Hitchcock Medical Center where he was Section Chief of Gastroenterology and Hepatology and Professor of Medicine at the Geisel School of Medicine at Dartmouth.
Dr. Lacy’s clinical and basic science research interests focus on disorders of gastrointestinal motility, with an emphasis on irritable bowel syndrome, achalasia, dyspepsia, gastroparesis, acid reflux disease, constipation, intestinal pseudo-obstruction and visceral pain. He is the author of over 175 peer-reviewed articles on gastrointestinal motility disorders and functional bowel disorders, in addition to multiple text book chapters. Dr. Lacy is a reviewer for a number of scientific journals, and is a member of a number of different scientific organizations, including the American College of Gastroenterology, the American Gastroenterology Association, and the American Neurogastroenterology & Motility Society. Dr. Lacy is the co-author of a book for the general public on acid reflux disease, "Healing Heartburn", is the author of "Making Sense of IBS", a book for the general public on irritable bowel syndrome, and edited and authored the books "Curbside Consultations in IBS", “Functional and Motility Disorders of the Gastrointestinal Tract” and “Essential Disorders of the Stomach and Small Intestine” for health care providers. Dr. Lacy is the current co-Editor in Chief of the American Journal of Gastroenterology. He is the former Editor in Chief of Clinical and Translational Gastroenterology. Dr. Lacy was the co-Chairman for the Rome IV Committee on Functional Bowel Disorders.
Mayo Clinic
Dr. Lembo ia a gastroenterologist clinician and researcher with an interest in Functional Gastrointestinal Disorders. He is the Director of the GI Motility and Functional Bowel Disorder Center at Beth Israel Deaconess Medical Center in Boston, MA. He is a Professor of Medicine at Harvard Medical School. His clinical practice and research has focused on the diagnosis, treatment, and management of such disorders, for example, Irritable Bowel Syndrome (IBS). He has carried out numerous clinical trials in IBS involving both pharmacological and alternative/complementary treatments, including placebo. He is member of the Rome Committee and as well as the AGA and ACG. I am also a co-author of the Rome IV criteria for IBS.
Harvard Medical School
Dr. Linda Nguyen is a Clinical Associate Professor, Director of the Neurogastroenterology & Motility Program, and the Clinic Chief in the Division of Gastroenterology & Hepatology at Stanford University. Dr. Nguyen completed medical school at UCLA School of Medicine and GI fellowship training at California Pacific Medical Center in San Francisco, CA under the mentorship of Dr. William Snape.
Her clinical and research interests include functional and motility disorders of the gut, with an emphasis on gastroparesis and functional dyspepsia with a special interest in visceral hypersensitivity and autonomic dysfunction. She was a member of the NIH/NIDDK Gastroparesis Clinical Research Consortium from 2007-2016. Her current research focuses on the role of neuromodulation on inflammation, physiology and symptoms. She is also passionate about quality of life, professional development and physician wellness.
Stanford University
Mark Pimentel, MD is the Executive Director of the Medically Associated Science and Technology (MAST) Program and Professor at Cedars-Sinai Medical Center. He is also Professor of Medicine at UCLA’s David Geffen School in Los Angeles, California. Dr. Pimentel completed 3 years of an undergraduate degree in honors microbiology and biochemistry at the University of Manitoba, Canada. This was followed by his medical degree, and his BSc (Med) from the University of Manitoba Health Sciences Center in Winnipeg, Manitoba, Canada, where he also completed a residency in internal medicine. His medical training includes a fellowship in gastroenterology at the UCLA Affiliated Training Program. Active in research, Dr. Pimentel has served as a principal investigator or co-investigator for numerous basic science, translational and clinical studies in such areas as IBS, and the relationship between gut flora composition and human disease. His work has been published in the New England Journal of Medicine, Annals of Internal Medicine, American Journal of Physiology, American Journal of Medicine, American Journal of Gastroenterology and Digestive Diseases and Sciences, among others. Dr. Pimentel has been invited to present his work at meetings, grand rounds, and advisory boards in the United States and Internationally. He is a diplomate of the American Board of Internal Medicine (Gastroenterology) and a fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Pimentel is also a member of several medical associations including the American Gastroenterological Association, the American College of Gastroenterology, and the American Neurogastroenterology and Motility Society.
A few of Dr. Pimentel’s most significant accomplishments include:
Cedars-Sinai
Recognitions
Training
Augusta university
Lucinda A. Harris, MS, MD, is currently Professor of Medicine, Mayo School of Medicine and Consultant, Division of Gastroenterology and Hepatology, Mayo Clinic Scottsdale. She graduated from the University of Connecticut School Of Medicine. She completed her Internal Medicine Residency at the New York Presbyterian Hospital of Columbia University and her fellowship in Gastroenterology & Hepatology at The New York Hospital /Weill Medical College of Cornell University. She was on the faculty in the Division of Gastroenterology & Hepatology at Weill Cornell Medical School before moving to her current position at Mayo Clinic.
At Mayo she has been a past Co-Director of the Motility Group and has led a patient support group there for IBS. She is a current member of the Gastroenterology Fellowship committee and serves as the Department Education coordinator for Gastroenterology supervising visiting GI fellows and medical students. She has actively been involved in mentoring medical students, residents, and fellows over the years.
Professionally, she is currently President of the Phoenix GI Society. She also is active in professional organizations as a Fellow of the American College of Gastroenterology, the American Gastroenterological Association, and the American College of Internal Medicine. She is also a member of American Neurogastroenterology and Motility Society. She is also a member of the Rome V- Age, Race, Gender, Women's Health & the Patient Committee. Her special clinical and research interests are in IBS, gastroparesis, chronic constipation, and pelvic floor disorders as well as celiac disease and autonomic disorders. She has written and lectured extensively on these topics.
Mayo Clinic
Christopher Andrews, MD, MSc, FRCPC, AGAF is a Gastroenterologist and Clinical Professor in the Department of Medicine at the University of Calgary Cumming School of Medicine. He has had advanced training in gastrointestinal motility and function at the Mayo Clinic, Rochester, USA where he also obtained a Masters' Degree in Clinical Health Research. He is GI Site Chief at Foothills Hospital, Calgary, and is Director of the Calgary Gut Motility Centre, the largest such Centre in Canada. Dr. Andrews specializes clinically in motility disorders, in addition to early-stage development of novel diagnostic and therapeutic approaches related to gut function.
University of Calgary
Dr. Schmulson is Professor of Medicine of the Universidad Nacional Autónoma de México (UNAM) and currently works in the Laboratory of Liver, Pancreas and Motility (HIPAM) of the Department of Experimental Medicine located in the Hospital General de México. His research is focused on the epidemiology, quality of life of FGIDs and on the immunological factors associated with IBS.
Dr. Schmulson also works in Clínica Lomas Altas in Mexico City where he runs the Motility Unit as well as in the ABC Hospital. He is a member of the National System of Researchers (SNI-CONACyT) and of the National Academy of Medicine of Mexico. He has published more than 60 papers in peer review journals, 45 chapters in books and has edited two books. He has received the award “Dr. Abraham Ayala González” in Clinical Research on five opportunities and the Epidemiological Research award from the Mexican Gastroenterological Association. In 2006 he was one of the founders of the Latin American Society for Neurogastroenterology (SLNG) and served as the first president, and serves in the External Medical Advisory Board of the IFFGD. He is currently Editor in Chief of the Revista de Gastroenterología de México and Associated Editor of the American Journal of Gastroenterology.
Dr. Schmulson worked on the Spanish translation of the Rome II Modular Questionnaire and Rome III Adult Questionnaire and served on the Management and Design of Treatment Trials Committee of the Rome CD Slide Set. He was a charter member of the Rome Foundation International Liaison Committee and served as Chair from 2009 to May 2013. He is a member of the Multinational Working Team of the Rome Foundation that recently released its report and is currently serving as member of the Multi-Cultural Aspects and Design of Treatment Trials chapters of Rome IV and in the IBS Global Study Executive Committee.
Universidad Nacional Autónoma de México
